Home Tags Anne S. De Groot

Tag: Anne S. De Groot

EPIVAX AND CUBRC have been awarded a two-year, $1 million federal contract from the U.S. Food and Drug Administration to establish best practices and procedures for assessing generic peptides and related impurities for immunogenic potential. EpiVax CEO and Chief Science Officer Dr. Anne S. De Groot said generic peptides drugs are a quickly growing market. / PBN FILE PHOTO/MICHAEL SALERNO

EpiVax and CUBRC win $1M FDA contract to establish best practices...

PROVIDENCE – EpiVax Inc. and CUBRC Inc. have been awarded a two-year, $1 million federal contract from the U.S. Food and Drug Administration to...
EPIVAX HAS WON a $324,000 grant to develop a web tool that will quickly determine whether Pompe disease patients are at risk for an immune response to enzyme replacement therapy.

EpiVax wins $324K NIH grant to improve Pompe disease treatment

PROVIDENCE — EpiVax Inc. has received a $324,980 Small Business Innovation Research grant to continue development of a web-based test for people at risk...
FAST SEQUENCING: Dr. Anne S. De Groot, EpiVax Inc. CEO and chief strategy officer, says the Providence company has spent the past 20 years developing immunoinformatics tools. EpiVax spinoff EpiVax Oncology will use those tools along with fast sequencing to design cancer vaccines specific to individual patients. / PBN PHOTO/MICHAEL SALERNO

Renowned vaccine researcher Dr. Anne S. De Groot is ready to...

In 1997, Dr. Anne S. De Groot founded EpiVax Inc. in ­Providence, backed by a Small Business Innovation Research grant from the National Institutes...

Public investment in basic research yields major victories

Dr. Anne S. De Groot is a major success story, not just in Rhode Island but across the globe.She bridges the research and clinical...
FULLY ENGAGED: EpiVax staff know that what they are working on has a real impact on health, and with a highly collaborative workplace, they all are an important part of the work. / COURTESY EPIVAX

Small companies, 18, EpiVax Inc.

Employees in R.I.: 24 Founder, CEO and Chief Science Officer Dr. Anne S. De Groot Questions answered by: Stephanie Vece, human resources managerWhat three words best...
- Featured Event -

Latest News